Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / GENOMIC BIOTECH
-
Total 13F shares
-
11,189,797
-
Share change
-
+669,633
-
Total reported value
-
$137,851,961
-
Put/Call ratio
-
0%
-
Price per share
-
$12.32
-
Number of holders
-
61
-
Value change
-
+$8,218,967
-
Number of buys
-
28
-
Number of sells
-
21
Institutional Holders of GLOBAL X FDS - GENOMIC BIOTECH (GNOM) as of Q1 2023
As of 31 Mar 2023,
GLOBAL X FDS - GENOMIC BIOTECH (GNOM) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,189,797 shares.
The largest 10 holders included
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, Private Advisor Group, LLC, One Capital Management, LLC, Mirae Asset Global Investments Co., Ltd., Lido Advisors, LLC, Portland Global Advisors LLC, Prosperity Financial Group, Inc., Raymond James Financial Services Advisors, Inc., UBS Group AG, and McGuire Investment Group, LLC.
This page lists
62
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.